Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Sinopharm/Oramed Deal Sets Up Huge China Market For Oral Insulin

11 Dec 2015

• By Ying Huang

Related Companies

Oramed Pharmaceuticals Inc.

Rani Therapeutics Holdings, Inc.

Aphios Corporation

Emisphere Technologies, Inc.

Novo Nordisk A/S

Emisphere Technologies, Inc.

Bioton S.A.

Bioton S.A.

Eli Lilly and Company

Additional Topics

China Asia Pacific Israel Middle East and Africa Business Strategies Clinical Trials Deals Emerging Markets Platform Technologies BioPharmaceutical

More from China

More from Focus On Asia

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.